Is it appropriate to initiate medroxyprogesterone acetate (Depo‑Provera) injection in a sexually active 15‑year‑old female seeking hormonal contraception with no contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Depo-Provera is appropriate to initiate in a sexually active 15-year-old with no contraindications.

DMPA (Depo-Provera) may be safely recommended for adolescents and is highly effective, with typical-use pregnancy rates of approximately 6% in the first year 1. The 2014 American Academy of Pediatrics guidelines explicitly state that DMPA is appropriate for adolescents, can be initiated same-day ("quick start") if pregnancy is reasonably excluded, and offers significant advantages for this age group 1, 2.

Key Advantages for Adolescents

DMPA is particularly well-suited for adolescents because:

  • Ease of use: Requires only quarterly injections (every 13 weeks, up to 15 weeks) rather than daily adherence, making it more practical than pills for teens with irregular schedules 1
  • Privacy: Discrete method with no visible signs of use
  • Additional benefits: Improves dysmenorrhea, protects against iron-deficiency anemia and endometrial cancer, may raise seizure threshold and decrease sickle cell crises 2
  • Same-day initiation: Can start immediately without waiting for menses, with backup contraception (condoms) for the first 7 days 1

Critical Counseling Points

Menstrual Changes

Nearly all patients initially experience menstrual irregularities (spotting, irregular bleeding), which typically improve over time and often lead to amenorrhea—many teens view this as an advantage 1. Pre-injection counseling about these changes significantly improves continuation rates 1.

Bone Mineral Density Concerns

The FDA black-box warning about BMD loss requires careful discussion 3:

  • Adolescent-specific data: Studies show mean BMD decreases of 2.75% at total hip and 2.47% at lumbar spine after 1.2 years, with greater losses at longer durations 3
  • Recovery patterns: BMD partially recovers after discontinuation, but adolescents using DMPA >2 years showed incomplete recovery at hip and femoral neck even 60 months post-treatment 3
  • Current guidance: ACOG does not recommend limiting use to 2 years, recognizing that pregnancy risk outweighs BMD concerns 1. However, consider other risk factors for osteoporosis (eating disorders, chronic corticosteroid use, smoking, family history)

All patients should be counseled to ensure daily intake of 1300 mg calcium and 600 IU vitamin D, participate in regular weight-bearing exercise, and avoid smoking 1, 2, 1.

Weight Considerations

While weight gain is a common concern, evidence is mixed 2:

  • Early weight gain (>5% baseline weight at 6 months) predicts continued excessive weight gain 1
  • Not all patients gain weight—approximately 21% of adolescents become "early gainers" 2
  • Monitor weight at follow-up visits and counsel accordingly 4

Practical Implementation

Schedule injections every 11-12 weeks for adolescents to allow buffer for missed appointments 1. The grace period extends to 2 weeks late (15 weeks from last injection) without additional contraception needed 4.

Always emphasize condom use for STI protection, as DMPA provides no protection against infections 1.

When to Consider Alternatives

While DMPA is appropriate, strongly encourage alternatives if the patient has:

  • Eating disorders
  • Chronic corticosteroid use
  • Strong family history of osteoporosis
  • Tobacco use (counsel cessation)
  • Concerns about weight gain or irregular bleeding 2

In these scenarios, consider IUDs (which have higher continuation rates in adolescents and avoid BMD effects) or combined hormonal methods 1, 2.

Common Pitfalls

  1. Failing to provide same-day initiation: This increases pregnancy risk. Quick-start is safe and recommended 1, 5
  2. Inadequate pre-injection counseling: Teens who understand bleeding patterns beforehand are more likely to continue 1
  3. Over-emphasizing BMD concerns: While real, the pregnancy risk in sexually active teens without effective contraception poses greater health risks 1
  4. Not offering self-administration: Subcutaneous DMPA can be self-administered by adolescents, improving access and autonomy 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.